Interview with the CEO on Ozbiz small caps segment today.
Interesting clarity and very informative.
The usual lack of 'zing' , with conservative outlooks.
Standard company behaviour I guess.
Hopefully they can achieve the usual under promises and over delivery.
Sounded just like the standard surgeon's answers, tbh.
Definitely an exciting future for the company into the future should all products have strong US market penetration, which too will hopefully provide a very smooth runway into the other world markets.
Ann: AROA secures first FDA clearance for ENIVO system, page-5
Add ARX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
0.010(1.85%) |
Mkt cap ! $189.3M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 56.0¢ | 54.5¢ | $61.23K | 110.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 22665 | 2 |
View Market Depth
| Last trade - 15.47pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
55.5¢ |
Change
0.010 ( 1.57 %) |
||||
| Open | High | Low | Volume | ||
| 55.0¢ | 56.0¢ | 54.5¢ | 113900 | ||
| Last updated 14.49pm 05/06/2024 ? | |||||
| ARX (ASX) Chart |